title: Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment.
authors.forename: R
authors.initials: R
authors.lastname: Thonhofer
authors.forename: M
authors.initials: M
authors.lastname: Gaugg
authors.forename: M
authors.initials: M
authors.lastname: Kriessmayr
authors.forename: H J
authors.initials: HJ
authors.lastname: Neumann
authors.forename: L
authors.initials: L
authors.lastname: Erlacher
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D016393:Lymphoma, B-Cell / Q000139:chemically induced* / Q000276:immunology; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009365:Neoplasm Regression, Spontaneous; D010255:Paranasal Sinus Neoplasms / Q000139:chemically induced* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; D008727:Methotrexate